Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chlebowski

Showing results (191-200 of 379) with videos related to

Pageof 38
Sort By:
Breast Cancer Research and Treatment|November 26, 2015
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicityR T Chlebowski, R Haque, H Hedlin, et al.
Journal of the National Cancer Institute|August 25, 2010
Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational studyChristopher I Li, Rowan T Chlebowski, Matthew Freiberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Migraine history and breast cancer risk among postmenopausal womenChristopher I Li, Robert W Mathes, Elizabeth C Bluhm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessmentRobin T Zon, Elizabeth Goss, Victor G Vogel, et al.
Journal of the Academy of Nutrition and Dietetics|August 23, 2017
Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women's Health InitiativeCynthia A Thomson, Tracy E Crane, David O Garcia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 24, 2017
Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal WomenGeoffrey C Kabat, Mimi Y Kim, Jennifer S Lee, et al.
Plos One|September 22, 2017
Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health InitiativeNa-Jin Park, Yuefang Chang, Catherine Bender, et al.
Journal of the National Cancer Institute|September 20, 2017
Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled TrialLi Jiao, Liang Chen, Donna L White, et al.
Annals of Epidemiology|April 30, 2013
Frequency of private spiritual activity and cardiovascular risk in postmenopausal women: the Women's Health InitiativeElena Salmoirago-Blotcher, George Fitchett, Kathleen M Hovey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionRowan T Chlebowski, Nananda Col, Eric P Winer, et al.
Pageof 38

Showing results (191-200 of 379) with videos related to

Sort By:
Pageof 38
Breast Cancer Research and Treatment|November 26, 2015
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicityR T Chlebowski, R Haque, H Hedlin, et al.
Journal of the National Cancer Institute|August 25, 2010
Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational studyChristopher I Li, Rowan T Chlebowski, Matthew Freiberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Migraine history and breast cancer risk among postmenopausal womenChristopher I Li, Robert W Mathes, Elizabeth C Bluhm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessmentRobin T Zon, Elizabeth Goss, Victor G Vogel, et al.
Journal of the Academy of Nutrition and Dietetics|August 23, 2017
Association between Dietary Energy Density and Obesity-Associated Cancer: Results from the Women's Health InitiativeCynthia A Thomson, Tracy E Crane, David O Garcia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 24, 2017
Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal WomenGeoffrey C Kabat, Mimi Y Kim, Jennifer S Lee, et al.
Plos One|September 22, 2017
Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health InitiativeNa-Jin Park, Yuefang Chang, Catherine Bender, et al.
Journal of the National Cancer Institute|September 20, 2017
Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled TrialLi Jiao, Liang Chen, Donna L White, et al.
Annals of Epidemiology|April 30, 2013
Frequency of private spiritual activity and cardiovascular risk in postmenopausal women: the Women's Health InitiativeElena Salmoirago-Blotcher, George Fitchett, Kathleen M Hovey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionRowan T Chlebowski, Nananda Col, Eric P Winer, et al.
Pageof 38